Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells
Condition(s):Hodgkin Disease; Non-Hodgkin Lymphoma; Multiple Myeloma; BacteremiaLast Updated:June 29, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Hodgkin Disease; Non-Hodgkin Lymphoma; Multiple Myeloma; BacteremiaLast Updated:June 29, 2015Completed
Condition(s):Cataract ExtractionLast Updated:July 23, 2012Completed
Condition(s):Cardiac ToxicityLast Updated:April 21, 2014Unknown status
Condition(s):Pulmonary TuberculosisLast Updated:December 5, 2019Unknown status
Condition(s):PneumoniaLast Updated:December 10, 2012Completed
Condition(s):TuberculosisLast Updated:November 18, 2016Terminated
Condition(s):TuberculosisLast Updated:June 8, 2011Completed
Condition(s):Community-acquired Bacterial PneumoniaLast Updated:March 3, 2017Completed
Condition(s):Bacterial ConjunctivitisLast Updated:May 12, 2015Completed
Condition(s):Corneal Health; Cataract SurgeryLast Updated:October 19, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.